SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
18394168
Source:
http://linkedlifedata.com/resource/pubmed/id/18394168
Search
Subject
(
76
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0036341
,
umls-concept:C0040615
,
umls-concept:C0087111
,
umls-concept:C0220812
,
umls-concept:C2922974
pubmed:dateCreated
2008-5-2
pubmed:abstractText
This study compared the costs of antipsychotic polypharmacy for patients who initiated on 1 of the 3 most commonly prescribed atypical antipsychotics - olanzapine, quetiapine, or risperidone.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-10217396
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-10453794
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-10572323
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-11387789
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-11874226
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-12047009
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-12047017
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-12047024
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-12366465
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-12509667
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-12616846
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-12765741
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-12795493
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-12841799
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-14578539
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-14720128
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-15000267
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-15056517
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-15093956
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-15176758
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-15491242
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-15899104
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-15921508
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-16401150
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-16889456
,
http://linkedlifedata.com/resource/pubmed/commentcorrection/18394168-17070017
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/100968559
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antipsychotic Agents
,
http://linkedlifedata.com/resource/pubmed/chemical/Benzodiazepines
,
http://linkedlifedata.com/resource/pubmed/chemical/Dibenzothiazepines
,
http://linkedlifedata.com/resource/pubmed/chemical/Risperidone
,
http://linkedlifedata.com/resource/pubmed/chemical/olanzapine
,
http://linkedlifedata.com/resource/pubmed/chemical/quetiapine
pubmed:status
MEDLINE
pubmed:issn
1471-244X
pubmed:author
pubmed-author:Ascher-SvanumHayaH
,
pubmed-author:CorrellChristoph UCU
,
pubmed-author:FariesDouglas EDE
,
pubmed-author:KaneJohn MJM
,
pubmed-author:ZhuBaojinB
pubmed:issnType
Electronic
pubmed:volume
8
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
19
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed-meshheading:18394168-Adult
,
pubmed-meshheading:18394168-Antipsychotic Agents
,
pubmed-meshheading:18394168-Benzodiazepines
,
pubmed-meshheading:18394168-Dibenzothiazepines
,
pubmed-meshheading:18394168-Female
,
pubmed-meshheading:18394168-Humans
,
pubmed-meshheading:18394168-Male
,
pubmed-meshheading:18394168-Mental Health Services
,
pubmed-meshheading:18394168-Polypharmacy
,
pubmed-meshheading:18394168-Prospective Studies
,
pubmed-meshheading:18394168-Risperidone
,
pubmed-meshheading:18394168-Schizophrenia
,
pubmed-meshheading:18394168-United States
pubmed:year
2008
pubmed:articleTitle
Cost of antipsychotic polypharmacy in the treatment of schizophrenia.
pubmed:affiliation
Eli Lilly and Company, Indianapolis, Indiana, USA. zhu_baojin@lilly.com
pubmed:publicationType
Journal Article
,
Comparative Study
,
Research Support, Non-U.S. Gov't
,
Multicenter Study